Buy Tesamorelin 20mg Research Peptide Online
Tesamorelin (20mg lyophilized formulation) enables comprehensive preclinical research programs requiring extended compound availability and supply capacity. This maximum-quantity formulation supports large-scale dose-escalation studies, pharmacokinetic investigations, and animal model protocols examining somatotropic axis modulation in detail.
Tesamorelin Peptide Identification & Structure
Tesamorelin represents a synthetic 44-amino acid growth hormone-releasing hormone (GHRH) agonist incorporating hexarelin modifications (D-Ala2 substitution). This structural enhancement confers superior receptor binding affinity and proteolytic resistance compared to native GHRH. The lyophilized acetate formulation provides optimal stability for long-term research storage.
Tesamorelin Mechanism of Action in Research Models
Preclinical investigation reveals tesamorelin selectivity for GHRH receptors expressed on anterior pituitary somatotrophs. In vitro dose-response studies document concentration-dependent GH secretion from pituitary explants and cultured somatotroph cell lines. Animal models demonstrate sustained growth hormone elevation supporting comprehensive investigation of endocrine axis regulation.
Tesamorelin Published Research Summary
Peer-reviewed research in Endocrinology and Hormones establishes tesamorelin pharmacology in preclinical systems. Studies document receptor pharmacodynamics, GH secretion profiles, and downstream metabolic effects in animal models. Literature supports investigation of tesamorelin mechanisms relevant to understanding growth hormone regulation in controlled research environments.
Tesamorelin 20mg Product Specifications & Handling
– Form: Lyophilized powder (acetate salt formulation) – Quantity: 20mg – Purity: Research-grade (98%+) – Storage: -20°C freezer optimal; protect from light and moisture – Reconstitution: Sterile saline or bacteriostatic water; room temperature equilibration before use – Stability: 2-3 weeks refrigerated when reconstituted
Tesamorelin Research Use Only Disclaimer
Tesamorelin is designated for preclinical research, in vitro studies, and laboratory investigation exclusively. Not approved for human consumption, veterinary use, or therapeutic application. All use must comply with institutional research guidelines and regulatory requirements.